Comparing Extracorporeal Shock Wave Therapy and Ultrasound-Guided Ozone Injection for Treating Chronic Lateral Epicondylitis in Adults Aged 18 to 65

What this Trial Is About

Lateral epicondylitis is a painful condition affecting the outer part of the elbow, often becoming chronic and resistant to standard treatments. This trial compares two treatments for patients with chronic, treatment-resistant lateral epicondylitis Extracorporeal Shock Wave Therapy ESWT and ultrasound-guided ozone injection. The study aims to evaluate which treatment offers better clinical and structural improvements for patients suffering from this condition. Participants will be randomly assigned to either the ESWT group or the ozone injection group. The ESWT group will receive shock wave therapy once a week for three weeks, with each session delivering 2000 impulses targeted to the affected tendon. The ozone injection group will receive an oxygen-ozone gas mixture injected under ultrasound guidance into the tendon once weekly for three weeks. Both treatments follow their standard protocols. Throughout the study, participants will be assessed at three times before treatment, immediately after the 3-week treatment period, and at a 4-week follow-up. Researchers will measure pain using the Visual Analog Scale VAS, function with the Patient-Rated Tennis Elbow Evaluation PRTEE, grip strength with a dynamometer, and tendon changes via high-resolution ultrasound. These assessments help determine treatment effects and monitor safety during the trial period.

Comparison of ESWT and Ultrasound-Guided Ozone Injection in Lateral Epicondylitis